Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 11.80
-0.33 (-2.72%)
At close: Mar 20, 2026
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 4.76 billion as of March 20, 2026. Its market cap has increased by 16.88% in one year.
Market Cap
4.76B
Enterprise Value
4.05B
Revenue
672.38M
Ranking
n/a
PE Ratio
39.13
Stock Price
11.80
Market Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has decreased from 5.31B to 4.76B, a decrease of -10.40%. That is a compound annual growth rate of -3.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 4.63B | 0.08% |
| Dec 31, 2025 | 4.62B | 19.35% |
| Dec 31, 2024 | 3.87B | -6.96% |
| Dec 29, 2023 | 4.16B | 8.12% |
| Dec 30, 2022 | 3.85B | -27.46% |
| Nov 16, 2022 | 5.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hunan Fangsheng Pharmaceutical | 5.03B |
| Fuan Pharmaceutical (Group) | 4.94B |
| Jianmin Pharmaceutical Group | 4.81B |
| Tibet Weixinkang Medicine | 4.74B |
| Zhejiang Yatai Pharmaceutical | 4.72B |
| Bide Pharmatech | 4.69B |
| Jinhe Biotechnology CO., LTD. | 4.64B |
| Jinling Pharmaceutical Company | 4.63B |